Mucodel Pharma

Mucodel Pharma is a specialty pharmaceutical company based in Greensboro, North Carolina, dedicated to the development of enhanced rescue therapies through its proprietary Co-Gel delivery platform. The Co-Gel technology is a multi-chambered, oromucosal delivery system that enables the rapid absorption of drugs through the buccal or sublingual mucosa, providing a non-invasive alternative to injections. The company's lead product candidate, Exonal (buccal naloxone), is designed for the emergency reversal of opioid overdose and has demonstrated pharmacokinetic profiles comparable to intramuscular administration in pilot clinical trials. Mucodel's pipeline also includes buccal formulations of diazepam for panic disorder and undisclosed analgesics for acute pain management. By leveraging its platform to repurpose existing FDA-approved agents, Mucodel aims to provide more reliable and user-friendly treatment options for critical medical situations.